FDA’s views on Vuse have potential to change the whole vaping landscape

It’s not often a vaping story makes the front page of The New York Times, but this was a big story – big enough for The Wall Street Journal, CNBC, Bloomberg and the BBC all to carry their own versions, big enough to go all round the world’s press thanks to the Reuters and Associated Press news agencies. After millions of marketing denial orders (MDOs), the US Food and Drug Administration (FDA) had issued its first marketing authorisations for e-cigarettes.

The granting of RJ Reynolds’s premarket tobacco product applications (PMTAs) for its Vuse Solo e-cigarette device and two of its pods is very big news for the US vaping industry, its supporters, its customers, and its opponents, for two reasons in particular.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ FDA’s views on Vuse have potential to change the whole vaping landscape ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ FDA’s views on Vuse have potential to change the whole vaping landscape ”






      It’s not often a vaping story makes the front page of The New York Times, but this was a big story – big enough for The Wall Street Journal, CNBC, Bloomberg and the BBC all to carry their own versions, big enough to go all round the world’s press thanks to the Reuters and Associated Press news agencies. After millions of marketing denial orders (MDOs), the US Food and Drug Administration (FDA) had issued its first marketing authorisations for e-cigarettes.

      The granting of RJ Reynolds’s premarket tobacco product applications (PMTAs) for its Vuse Solo e-cigarette device and two of its pods is very big news for the US vaping industry, its supporters, its customers, and its opponents, for two reasons in particular.

      ...

      Restricted content. Do you want to read more?